Market
Outcome of ex-McKinsey partner's legal case by end of 2025?
3
Resolution / Starting Odds
Guilty plea • 25%
Conviction after trial • 25%
Acquittal • 25%
Case dismissed • 25%
Court records and official announcements from the judicial system
Story
FBI Boston: McKinsey to Pay $650 Million to Settle U.S. Opioid Probe Linked to Purdue Pharma on December 13, 2024
Dec 13, 2024, 02:18 PM
McKinsey & Company has agreed to pay $650 million to settle a U.S. Department of Justice investigation into its advisory role in promoting opioid sales, specifically for Purdue Pharma, the manufacturer of OxyContin. This settlement resolves both criminal and civil investigations into the consulting firm's actions, which have been linked to the opioid epidemic in the United States. The announcement was made during a news conference held by the FBI in Boston, where details about the resolution of these investigations were shared. Additionally, an ex-partner of McKinsey is expected to plead guilty to obstruction as part of the settlement.
View original story
Similar markets
Ongoing legal proceedings • 25%
Guilty plea and sentencing • 25%
Not guilty verdict • 25%
Case dismissed • 25%
Yes • 50%
No • 50%
Case dismissed • 25%
Not guilty • 25%
Guilty on all charges • 25%
Guilty on some charges • 25%
Case Dismissed • 25%
Plea Deal • 25%
Acquitted • 25%
Convicted • 25%
Convicted of assault • 25%
Charges dropped • 25%
Plea deal reached • 25%
Case dismissed • 25%
Guilty of assault • 25%
Not guilty • 25%
Other outcome • 25%
Yes • 50%
No • 50%
Convicted and sentenced to prison • 25%
Case dismissed • 25%
Acquitted • 25%
Convicted but no prison sentence • 25%
No • 50%
Yes • 50%
Convicted • 25%
Mistrial • 25%
Plea deal • 25%
Acquitted • 25%
Settlement reached • 25%
Kiesewetter found guilty • 25%
Kiesewetter found not guilty • 25%
Case dismissed • 25%